Artemisinin-Quinidine Combination for Suppressing Ventricular Tachyarrhythmia in an Ex Vivo Model of Brugada Syndrome
Journal of Korean Medical Science · 2025
DOI: 10.3346/jkms.2025.40.e2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Korean Medical Science, 2025. Verfasst von Hyung Ki Jeong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Wonkwang University School of Medicine, Iksan, Korea. Hauptthemen laut MEDLINE: Quinidine, Anti-Arrhythmia Agents, Tachycardia, Ventricular, Brugada Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
BACKGROUND: The ionic mechanism underlying Brugada syndrome (BrS) arises from an imbalance in transient outward current flow between the epicardium and endocardium. Previous studies report that artemisinin, originally derived from a Chinese herb for antimalarial use, inhibits the Ito current in canines. In a prior study, we showed the antiarrhythmic effects of artemisinin in BrS wedge preparation models. However, quinidine remains a well-established antiarrhythmic agent for treating BrS. Therefore, this study aims to investigate the efficacy of combining artemisinin with low-dose quinidine in suppressing ventricular tachyarrhythmia (VTA) in experimental canine BrS models. METHODS: Transmural pseudo-electrocardiogram and epicardial/endocardial action potential (AP) were recorded from coronary-perfused canine right ventricular wedge preparation. To mimic the BrS model, acetylcholine (3 μM), calcium channel blocker verapamil (1 μM), and Ito agonist NS5806 (6-10 μM) were administered until VTA was induced. Subsequently, low-dose quinidine (1-2 μM) combined with artemisinin (100 μM) was perfused to mitigate VTA. Key parameters, including AP duration, J wave area, notch index, and T wave dispersion, were measured. RESULTS: After administering the provocation agents, all sample models exhibited prominent J waves and VTA. Artemisinin alone (100-150 μM) suppressed VTA and restored the AP dome in all three preparations. Its infusion resulted in reductions in the J wave area and epicardial notch index. Consequently, low-dose quinidine (1-2 μM) did not fully restore the AP dome in all six sample models. However, when combined with additional artemisinin (100 μM), low-dose quinidine effectively suppressed VTA in all six models and restored the AP dome while also decreasing the J wave area and epicardial notch index. CONCLUSION: Low-dose quinidine alone fails to fully alleviate VTA in the BrS wedge model. However, its combination with artemisinin effectively suppresses VTA. Artemisinin may reduce the therapeutic dose of quinidine, potentially minimizing its associated adverse effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Internal Medicine, Wonkwang University School of Medicine, Iksan, Korea.
- Institute of Wonkang Medical Science, Iksan, Korea.
- Division of Cardiology, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
- Department of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju, Korea. yoonnamsik@gmail.com.
- Department of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju, Korea.
ORCID-Profile: Hyung Ki Jeong, Namsik Yoon, Yoo Ri Kim, Ki Hong Lee, Hyung Wook Park
Förderung
- National Research Foundation of Korea
Zitieren
APA
Jeong, H. K., Yoon, N., Kim, Y. R., Lee, K. H., & Park, H. W. (2025). Artemisinin-Quinidine Combination for Suppressing Ventricular Tachyarrhythmia in an Ex Vivo Model of Brugada Syndrome. Journal of Korean Medical Science. https://doi.org/10.3346/jkms.2025.40.e2
Vancouver
Jeong HK, Yoon N, Kim YR, Lee KH, Park HW. Artemisinin-Quinidine Combination for Suppressing Ventricular Tachyarrhythmia in an Ex Vivo Model of Brugada Syndrome. Journal of Korean Medical Science. 2025. doi:10.3346/jkms.2025.40.e2
BibTeX
@article{Jeong2025,
author = {Jeong, Hyung Ki and Yoon, Namsik and Kim, Yoo Ri and Lee, Ki Hong and Park, Hyung Wook},
title = {Artemisinin-Quinidine Combination for Suppressing Ventricular Tachyarrhythmia in an Ex Vivo Model of Brugada Syndrome},
journal = {Journal of Korean Medical Science},
year = {2025},
doi = {10.3346/jkms.2025.40.e2}
}
EUVIMED